Screening for Ovarian Cancer: Recommendations and Rationale.Deals with the screening for ovarian cancer. Techniques for screening; Rationale for screening; Recommendations on screening.EBSCO_AspAnnals of Internal Medicine
Screening for Ovarian Cancer in Asymptomatic Women JAMA Editorial February 13, 2018 Screening for Ovarian Cancer JAMA JAMA Patient Page February 13, 2018 This JAMA Patient Page discusses the US Preventive Services Task Force’s recommendations on screening for ovarian cancer in asymptomatic women. The...
In addition, the advent of next-generation sequencing, which allows for cost-effective screening of multiple genes simultaneously, may detect other gene mutations associated with an increased risk of breast and ovarian cancer that might also warrant inclusion in genetic testing. At this point, ...
Screening for ovarian cancer usually consists of cancer antigen (CA)-125 serum testing alone or in conjunction with transvaginal ultrasonography. "The evaluation of abnormal test results consists of either repeat testing or, frequently, removal of one or both of the ovaries via laparoscopy or laparot...
"This is the first-ever evidence to suggest that screening for early detection of ovarian cancer may save lives," Ian Jacobs, MD, president and vice-chancellor of the University of New South Wales in Sydney, Australia, toldMedscape Medical News. ...
National Center for Health Statistics; 2019. 31. Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc. 2017;86(1):18-33. doi:10.1016/...
Uptake of screening and risk-reducing recommendations among women with hereditary breast and ovarian cancer syndrome due to pathogenic BRCA1/2 variants eva... Purpose Carriers of pathogenic variants in BRCA1/2 have an elevated lifetime cancer risk warranting high-risk screening and risk-reducing proc...
Screening for ovarian cancer is not effective 来自 onAcademic 喜欢 0 阅读量: 16 作者: N Siva 摘要: Endocrine treatment for breast cancer was introduced more than a century ago. The discovery of hormone receptors has allowed targeting of endocrine treatment to patients whose primary tumours express...
Objective: To provide physicians with a current consensus on screening, prevention, diagnosis, and treatment of ovarian cancer. Participants: A non-federal, nonadvocate, 14-member consensus panel representing the fields of gynecologic, medical, and radiation oncology, obstetrics/gynecology, and biostatist...
Both HPV testing and VIA have been found to be effective in preventing cervical neoplasia and deaths caused by cervical cancer in clinical trials.12, 14, 15, 16 Recently, the World Health Organization (WHO) provided recommendations for screen-and-treat programs for comprehensive cervical cancer ...